[Perioperative care of epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa]

Gynecol Obstet Fertil Senol. 2019 Feb;47(2):187-196. doi: 10.1016/j.gofs.2018.12.005. Epub 2019 Jan 24.
[Article in French]

Abstract

The following recommendations cover the perioperative management of ovarian, Fallopian tube and primary peritoneal cancers. Five questions related to pre-habilitation and enhanced recovery after surgery were evaluated. The conclusions and recommendations are based on an analysis of the level of evidence available in the literature. These recommendations are part of the overall recommendations for improving the management of ovarian, fallopian or primary peritoneal cancer, made with the support of INCa (Institut National du Cancer). The main preoperative measures are screening for nutritional deficiencies (Grade B) and for anaemia (GradeC) in patients with ovarian cancer. It is not possible to make recommendations on the correction of malnutrition and/or anemia or on the contribution of pre-operative immuno-nutrition due to the absence of data in ovarian cancer, tube cancer or primary peritoneum cancer. For the same reasons, no recommendation can be made on the value of preoperative digestive preparation in ovarian, fallopian tube or primary peritoneum cancer. During surgery, goal-directed fluid therapy for patients with advanced ovarian cancer is recommended (Grade B). A single dose infusion of tranexamic acid is recommended for patients with ovarian, fallopian tube or primary peritoneal cancer (GradeC). For postoperative analgesia, epidural analgesia is recommended for patients undergoing cyto-reduction surgery by laparotomy (Grade B). In the absence of epidural analgesia, patient controlled analgesia with morphine without continuous infusion (Grade B) is recommended. No recommendation can be given regarding intravenous administration of lidocaine and/or ketamine during surgery, or, regarding peri-operatively prescription of gabapentin or pregabalin. In the absence of studies on the impact of different non-opiate analgesic combinations for ovarian cancer surgery, no recommendations can be made. Early oral feeding is recommended, including in cases of digestive resection (Grade B). The implementation of enhanced recovery programs, including early mobilization, is recommended (GradeC).

Keywords: Analgésie péridurale; Cancer de l’ovaire; Carence martiale; Carence nutritionnelle; De la trompe ou du péritoine primitif; Enhanced rehabilitation; Epidural analgesia; Individual stroke volume monitoring; Iron deficiency; Mechanical digestive preparation; Monitorage individualisé de la volémie; Nutritional deficiency; Ovarian; Perioperative care; Préparation digestive mécanique; Reprise de l’alimentation; Resumption of food; Réhabilitation améliorée; Soins périopératoires; Trunk or primitive peritoneum cancer.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Analgesia, Patient-Controlled
  • Anemia / etiology
  • Anemia / therapy
  • Antifibrinolytic Agents / therapeutic use
  • Blood Loss, Surgical / prevention & control
  • Carcinoma, Ovarian Epithelial / surgery*
  • Eating
  • Female
  • France
  • Humans
  • Ileostomy
  • Malnutrition / prevention & control
  • Nutritional Support
  • Ovarian Neoplasms / surgery*
  • Pain, Postoperative / prevention & control
  • Postoperative Care
  • Preoperative Care
  • Societies, Medical
  • Tranexamic Acid / therapeutic use

Substances

  • Antifibrinolytic Agents
  • Tranexamic Acid